Document Detail

Emerging options in the treatment of deep vein thrombosis and pulmonary embolism.
MedLine Citation:
PMID:  21605928     Owner:  NLM     Status:  Publisher    
The incidence of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is increasing and the disease has been found to account for over 500,000 annual deaths in the European Union. VTE is associated with increased mortality and may lead to serious long-term complications. Unfractionated heparin (UFH), low molecular weight heparin (LMWH) and vitamin K antagonists (VKA) have remained standard of care for many years. Recent trials of novel anticoagulants have indicated that new therapeutical options may soon become available. Studies on the role of new agents in VTE prevention in patients undergoing orthopaedic surgery have provided the evidence suggesting potential value of these drugs for the management of acute events. At present, investigation of new anticoagulants has reached the stage when phase III clinical studies on some novel agents have been completed and others are in progress. Of those furthest along are the direct Factor Xa inhibitors, rivaroxaban and apixaban, and the direct thrombin inhibitor, dabigatran. Findings of ongoing trials are expected to determine potential impact of these agents on current clinical practice.
Benjamin Brenner; Ron Hoffman
Related Documents :
3300448 - Postnatal regulation of the pulmonary circulation: a role for lipid mediators?
22458278 - Reverse elephant trunk technique: a novel approach to pseudoaneurysm repair.
6782058 - Hypoxemia and pulmonary gas exchange during hemodialysis.
22109828 - Reversible branch retinal artery occlusion following intravenous cisplatin chemotherapy...
833188 - Plasma heparin neutralizing activity in patients with valvular stenosis and prosthetic ...
2809978 - Aortic root replacement for complicated bacterial endocarditis in an infant.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-21
Journal Detail:
Title:  Blood reviews     Volume:  -     ISSN:  1532-1681     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708558     Medline TA:  Blood Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Muscle work is increased in pre-swing during hemiparetic walking.
Next Document:  Ozone affects pollen viability and NAD(P)H oxidase release from Ambrosia artemisiifolia pollen.